Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL PROLIFERATION |
66 |
1496 |
8.803e-20 |
4.096e-16 |
2 |
RESPONSE TO ENDOGENOUS STIMULUS |
62 |
1450 |
7.136e-18 |
1.66e-14 |
3 |
RESPONSE TO HORMONE |
48 |
893 |
1.146e-17 |
1.778e-14 |
4 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
48 |
917 |
3.292e-17 |
3.829e-14 |
5 |
RESPONSE TO LIPID |
47 |
888 |
4.827e-17 |
4.492e-14 |
6 |
RESPONSE TO ABIOTIC STIMULUS |
50 |
1024 |
1.106e-16 |
8.574e-14 |
7 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
58 |
1395 |
3.802e-16 |
2.527e-13 |
8 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
52 |
1142 |
4.428e-16 |
2.576e-13 |
9 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
57 |
1381 |
1.002e-15 |
5.18e-13 |
10 |
REGULATION OF CELL DIFFERENTIATION |
58 |
1492 |
7.469e-15 |
3.476e-12 |
11 |
TISSUE DEVELOPMENT |
58 |
1518 |
1.585e-14 |
6.706e-12 |
12 |
SMALL MOLECULE METABOLIC PROCESS |
63 |
1767 |
2.142e-14 |
8.305e-12 |
13 |
RESPONSE TO OXYGEN LEVELS |
26 |
311 |
2.85e-14 |
1.02e-11 |
14 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
41 |
823 |
4.805e-14 |
1.597e-11 |
15 |
NEUROGENESIS |
54 |
1402 |
1.146e-13 |
3.554e-11 |
16 |
CELL DEVELOPMENT |
54 |
1426 |
2.268e-13 |
6.594e-11 |
17 |
RESPONSE TO STEROID HORMONE |
31 |
497 |
2.451e-13 |
6.708e-11 |
18 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
47 |
1152 |
8.039e-13 |
2.078e-10 |
19 |
RESPONSE TO EXTERNAL STIMULUS |
61 |
1821 |
9.618e-13 |
2.355e-10 |
20 |
RESPONSE TO WOUNDING |
32 |
563 |
1.206e-12 |
2.551e-10 |
21 |
SENSORY ORGAN DEVELOPMENT |
30 |
493 |
1.154e-12 |
2.551e-10 |
22 |
GLAND DEVELOPMENT |
27 |
395 |
1.126e-12 |
2.551e-10 |
23 |
ORGANIC ACID METABOLIC PROCESS |
42 |
953 |
1.344e-12 |
2.719e-10 |
24 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
40 |
872 |
1.419e-12 |
2.751e-10 |
25 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
33 |
609 |
1.921e-12 |
3.575e-10 |
26 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
38 |
801 |
2.016e-12 |
3.608e-10 |
27 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
59 |
1784 |
4.294e-12 |
7.399e-10 |
28 |
SKELETAL SYSTEM DEVELOPMENT |
28 |
455 |
5.272e-12 |
8.761e-10 |
29 |
RESPONSE TO ALCOHOL |
25 |
362 |
6.481e-12 |
1.04e-09 |
30 |
ORGAN MORPHOGENESIS |
38 |
841 |
8.674e-12 |
1.302e-09 |
31 |
RESPONSE TO DRUG |
27 |
431 |
8.597e-12 |
1.302e-09 |
32 |
EMBRYO DEVELOPMENT |
39 |
894 |
1.292e-11 |
1.878e-09 |
33 |
EPITHELIUM DEVELOPMENT |
40 |
945 |
1.72e-11 |
2.425e-09 |
34 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
35 |
740 |
1.801e-11 |
2.464e-09 |
35 |
RESPONSE TO ACID CHEMICAL |
23 |
319 |
1.976e-11 |
2.554e-09 |
36 |
TUBE DEVELOPMENT |
30 |
552 |
1.969e-11 |
2.554e-09 |
37 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
58 |
1805 |
2.191e-11 |
2.756e-09 |
38 |
RESPONSE TO MECHANICAL STIMULUS |
19 |
210 |
2.429e-11 |
2.974e-09 |
39 |
EYE DEVELOPMENT |
23 |
326 |
3.064e-11 |
3.656e-09 |
40 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
41 |
1008 |
3.201e-11 |
3.724e-09 |
41 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
32 |
643 |
3.929e-11 |
4.459e-09 |
42 |
POSITIVE REGULATION OF GENE EXPRESSION |
56 |
1733 |
4.289e-11 |
4.752e-09 |
43 |
APPENDAGE DEVELOPMENT |
17 |
169 |
5.252e-11 |
5.554e-09 |
44 |
LIMB DEVELOPMENT |
17 |
169 |
5.252e-11 |
5.554e-09 |
45 |
NEGATIVE REGULATION OF GENE EXPRESSION |
51 |
1493 |
5.427e-11 |
5.612e-09 |
46 |
WOUND HEALING |
27 |
470 |
6.199e-11 |
6.271e-09 |
47 |
RESPONSE TO NITROGEN COMPOUND |
37 |
859 |
6.64e-11 |
6.573e-09 |
48 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
35 |
788 |
1.009e-10 |
9.581e-09 |
49 |
CIRCULATORY SYSTEM DEVELOPMENT |
35 |
788 |
1.009e-10 |
9.581e-09 |
50 |
TISSUE MORPHOGENESIS |
28 |
533 |
2.112e-10 |
1.965e-08 |
51 |
POSITIVE REGULATION OF CELL PROLIFERATION |
35 |
814 |
2.421e-10 |
2.181e-08 |
52 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
54 |
1710 |
2.438e-10 |
2.181e-08 |
53 |
EMBRYONIC MORPHOGENESIS |
28 |
539 |
2.725e-10 |
2.392e-08 |
54 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
53 |
1672 |
3.252e-10 |
2.802e-08 |
55 |
IMMUNE SYSTEM DEVELOPMENT |
29 |
582 |
3.385e-10 |
2.864e-08 |
56 |
HEAD DEVELOPMENT |
32 |
709 |
4.654e-10 |
3.867e-08 |
57 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
56 |
1848 |
4.915e-10 |
3.992e-08 |
58 |
ORGANONITROGEN COMPOUND METABOLIC PROCESS |
55 |
1796 |
4.976e-10 |
3.992e-08 |
59 |
OSSIFICATION |
19 |
251 |
5.227e-10 |
4.123e-08 |
60 |
REPRODUCTION |
45 |
1297 |
5.592e-10 |
4.337e-08 |
61 |
REGULATION OF BODY FLUID LEVELS |
26 |
506 |
1.553e-09 |
1.185e-07 |
62 |
SENSORY ORGAN MORPHOGENESIS |
18 |
239 |
1.64e-09 |
1.231e-07 |
63 |
MORPHOGENESIS OF AN EPITHELIUM |
23 |
400 |
1.719e-09 |
1.269e-07 |
64 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
33 |
799 |
2.28e-09 |
1.658e-07 |
65 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
45 |
1360 |
2.477e-09 |
1.773e-07 |
66 |
RESPONSE TO ESTROGEN |
17 |
218 |
2.782e-09 |
1.904e-07 |
67 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
37 |
983 |
2.766e-09 |
1.904e-07 |
68 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
50 |
1618 |
2.719e-09 |
1.904e-07 |
69 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
48 |
1517 |
2.829e-09 |
1.908e-07 |
70 |
OXIDATION REDUCTION PROCESS |
35 |
898 |
3.203e-09 |
2.111e-07 |
71 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
28 |
602 |
3.221e-09 |
2.111e-07 |
72 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
53 |
1791 |
3.69e-09 |
2.385e-07 |
73 |
REGULATION OF BINDING |
19 |
283 |
3.868e-09 |
2.465e-07 |
74 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
36 |
957 |
4.727e-09 |
2.972e-07 |
75 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
37 |
1004 |
4.87e-09 |
3.022e-07 |
76 |
RESPONSE TO ESTRADIOL |
14 |
146 |
5.13e-09 |
3.141e-07 |
77 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
28 |
616 |
5.324e-09 |
3.217e-07 |
78 |
REGULATION OF SECRETION |
30 |
699 |
5.455e-09 |
3.254e-07 |
79 |
REGULATION OF CELL DEVELOPMENT |
33 |
836 |
6.951e-09 |
4.094e-07 |
80 |
AGING |
18 |
264 |
7.91e-09 |
4.601e-07 |
81 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
24 |
472 |
8.397e-09 |
4.824e-07 |
82 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
14 |
152 |
8.653e-09 |
4.91e-07 |
83 |
REGULATION OF CELL DEATH |
46 |
1472 |
9.486e-09 |
5.318e-07 |
84 |
REGULATION OF CELLULAR LOCALIZATION |
42 |
1277 |
1.098e-08 |
6.083e-07 |
85 |
POSITIVE REGULATION OF CELL COMMUNICATION |
47 |
1532 |
1.129e-08 |
6.178e-07 |
86 |
BONE DEVELOPMENT |
14 |
156 |
1.21e-08 |
6.545e-07 |
87 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
19 |
304 |
1.243e-08 |
6.65e-07 |
88 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
22 |
408 |
1.268e-08 |
6.705e-07 |
89 |
REGULATION OF HOMEOSTATIC PROCESS |
23 |
447 |
1.4e-08 |
7.319e-07 |
90 |
REGENERATION |
14 |
161 |
1.814e-08 |
9.376e-07 |
91 |
OVULATION CYCLE |
12 |
113 |
2.065e-08 |
1.056e-06 |
92 |
RESPONSE TO NUTRIENT |
15 |
191 |
2.217e-08 |
1.121e-06 |
93 |
MONOCARBOXYLIC ACID METABOLIC PROCESS |
24 |
503 |
2.835e-08 |
1.418e-06 |
94 |
HEART DEVELOPMENT |
23 |
466 |
3.018e-08 |
1.494e-06 |
95 |
POSITIVE REGULATION OF TRANSPORT |
34 |
936 |
3.126e-08 |
1.531e-06 |
96 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
41 |
1275 |
3.163e-08 |
1.533e-06 |
97 |
CELL PROLIFERATION |
28 |
672 |
3.435e-08 |
1.648e-06 |
98 |
REGULATION OF TRANSPORT |
51 |
1804 |
3.484e-08 |
1.654e-06 |
99 |
LEUKOCYTE DIFFERENTIATION |
18 |
292 |
3.757e-08 |
1.766e-06 |
100 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
25 |
552 |
3.975e-08 |
1.85e-06 |
101 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
45 |
1492 |
4.068e-08 |
1.874e-06 |
102 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
24 |
513 |
4.11e-08 |
1.875e-06 |
103 |
CARTILAGE DEVELOPMENT |
13 |
147 |
4.835e-08 |
2.163e-06 |
104 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
17 |
264 |
4.819e-08 |
2.163e-06 |
105 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
30 |
771 |
4.922e-08 |
2.181e-06 |
106 |
RESPONSE TO EXTRACELLULAR STIMULUS |
22 |
441 |
5.065e-08 |
2.223e-06 |
107 |
SINGLE ORGANISM CATABOLIC PROCESS |
34 |
957 |
5.338e-08 |
2.321e-06 |
108 |
POSITIVE REGULATION OF CELL DEATH |
26 |
605 |
5.965e-08 |
2.57e-06 |
109 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
10 |
80 |
6.652e-08 |
2.84e-06 |
110 |
NEURON DIFFERENTIATION |
32 |
874 |
6.919e-08 |
2.927e-06 |
111 |
LOCOMOTION |
37 |
1114 |
7.257e-08 |
3.042e-06 |
112 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
35 |
1021 |
7.979e-08 |
3.315e-06 |
113 |
RESPONSE TO KETONE |
14 |
182 |
8.544e-08 |
3.518e-06 |
114 |
EPITHELIAL CELL DIFFERENTIATION |
23 |
495 |
9.033e-08 |
3.687e-06 |
115 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
15 |
216 |
1.133e-07 |
4.584e-06 |
116 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
37 |
1135 |
1.161e-07 |
4.659e-06 |
117 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
36 |
1087 |
1.196e-07 |
4.755e-06 |
118 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
22 |
465 |
1.276e-07 |
5.033e-06 |
119 |
REGULATION OF PROTEIN SECRETION |
20 |
389 |
1.295e-07 |
5.063e-06 |
120 |
CELLULAR COMPONENT MORPHOGENESIS |
32 |
900 |
1.346e-07 |
5.221e-06 |
121 |
MESENCHYMAL CELL DIFFERENTIATION |
12 |
134 |
1.393e-07 |
5.357e-06 |
122 |
STEM CELL DIFFERENTIATION |
14 |
190 |
1.458e-07 |
5.563e-06 |
123 |
TISSUE REMODELING |
10 |
87 |
1.496e-07 |
5.659e-06 |
124 |
EPIDERMIS DEVELOPMENT |
16 |
253 |
1.545e-07 |
5.797e-06 |
125 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
18 |
321 |
1.566e-07 |
5.83e-06 |
126 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
27 |
684 |
1.82e-07 |
6.722e-06 |
127 |
CONNECTIVE TISSUE DEVELOPMENT |
14 |
194 |
1.886e-07 |
6.911e-06 |
128 |
RESPONSE TO INORGANIC SUBSTANCE |
22 |
479 |
2.126e-07 |
7.73e-06 |
129 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
13 |
167 |
2.171e-07 |
7.83e-06 |
130 |
RESPIRATORY SYSTEM DEVELOPMENT |
14 |
197 |
2.278e-07 |
8.154e-06 |
131 |
REGULATION OF PROTEIN BINDING |
13 |
168 |
2.327e-07 |
8.265e-06 |
132 |
EMBRYONIC ORGAN DEVELOPMENT |
20 |
406 |
2.57e-07 |
9.061e-06 |
133 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
16 |
263 |
2.616e-07 |
9.152e-06 |
134 |
SKIN EPIDERMIS DEVELOPMENT |
9 |
71 |
2.706e-07 |
9.327e-06 |
135 |
DEVELOPMENTAL GROWTH |
18 |
333 |
2.697e-07 |
9.327e-06 |
136 |
RHYTHMIC PROCESS |
17 |
298 |
2.742e-07 |
9.381e-06 |
137 |
GROWTH |
20 |
410 |
3.004e-07 |
1.02e-05 |
138 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
28 |
750 |
3.304e-07 |
1.114e-05 |
139 |
CELLULAR RESPONSE TO ACID CHEMICAL |
13 |
175 |
3.73e-07 |
1.249e-05 |
140 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
37 |
1192 |
3.899e-07 |
1.296e-05 |
141 |
RESPONSE TO CORTICOSTEROID |
13 |
176 |
3.983e-07 |
1.314e-05 |
142 |
CELLULAR RESPONSE TO LIPID |
21 |
457 |
4.027e-07 |
1.32e-05 |
143 |
GLAND MORPHOGENESIS |
10 |
97 |
4.21e-07 |
1.37e-05 |
144 |
REGULATION OF OSSIFICATION |
13 |
178 |
4.535e-07 |
1.465e-05 |
145 |
RESPONSE TO VITAMIN |
10 |
98 |
4.637e-07 |
1.488e-05 |
146 |
SKIN DEVELOPMENT |
14 |
211 |
5.258e-07 |
1.676e-05 |
147 |
MULTICELLULAR ORGANISM REPRODUCTION |
28 |
768 |
5.312e-07 |
1.681e-05 |
148 |
REGULATION OF CHROMATIN ORGANIZATION |
12 |
152 |
5.501e-07 |
1.73e-05 |
149 |
CAMERA TYPE EYE MORPHOGENESIS |
10 |
101 |
6.153e-07 |
1.922e-05 |
150 |
BONE MORPHOGENESIS |
9 |
79 |
6.849e-07 |
2.124e-05 |
151 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
50 |
1929 |
6.982e-07 |
2.151e-05 |
152 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
20 |
437 |
8.179e-07 |
2.504e-05 |
153 |
REGULATION OF ORGANELLE ORGANIZATION |
36 |
1178 |
8.25e-07 |
2.509e-05 |
154 |
TUBE MORPHOGENESIS |
17 |
323 |
8.448e-07 |
2.553e-05 |
155 |
ODONTOGENESIS |
10 |
105 |
8.84e-07 |
2.654e-05 |
156 |
CELL ACTIVATION |
23 |
568 |
1.008e-06 |
3.006e-05 |
157 |
ORGAN REGENERATION |
9 |
83 |
1.047e-06 |
3.044e-05 |
158 |
HAIR CYCLE |
9 |
83 |
1.047e-06 |
3.044e-05 |
159 |
MOLTING CYCLE |
9 |
83 |
1.047e-06 |
3.044e-05 |
160 |
RESPONSE TO FATTY ACID |
9 |
83 |
1.047e-06 |
3.044e-05 |
161 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
30 |
891 |
1.07e-06 |
3.091e-05 |
162 |
REGULATION OF IMMUNE SYSTEM PROCESS |
40 |
1403 |
1.097e-06 |
3.152e-05 |
163 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
23 |
573 |
1.17e-06 |
3.341e-05 |
164 |
REGULATION OF TRANSFERASE ACTIVITY |
31 |
946 |
1.234e-06 |
3.5e-05 |
165 |
POSITIVE REGULATION OF SECRETION |
18 |
370 |
1.243e-06 |
3.506e-05 |
166 |
EAR DEVELOPMENT |
13 |
195 |
1.278e-06 |
3.574e-05 |
167 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
9 |
85 |
1.283e-06 |
3.574e-05 |
168 |
EYE MORPHOGENESIS |
11 |
136 |
1.293e-06 |
3.58e-05 |
169 |
REGULATION OF RESPONSE TO STRESS |
41 |
1468 |
1.334e-06 |
3.673e-05 |
170 |
REGULATION OF PROTEIN LOCALIZATION |
31 |
950 |
1.347e-06 |
3.688e-05 |
171 |
RESPONSE TO ALKALOID |
11 |
137 |
1.39e-06 |
3.782e-05 |
172 |
REGULATION OF HEART MORPHOGENESIS |
6 |
29 |
1.437e-06 |
3.866e-05 |
173 |
GLUCOSE CATABOLIC PROCESS |
6 |
29 |
1.437e-06 |
3.866e-05 |
174 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
22 |
541 |
1.632e-06 |
4.34e-05 |
175 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
22 |
541 |
1.632e-06 |
4.34e-05 |
176 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
16 |
303 |
1.712e-06 |
4.527e-05 |
177 |
SKELETAL SYSTEM MORPHOGENESIS |
13 |
201 |
1.794e-06 |
4.716e-05 |
178 |
POSITIVE REGULATION OF LOCOMOTION |
19 |
420 |
1.843e-06 |
4.749e-05 |
179 |
NEURON PROJECTION DEVELOPMENT |
22 |
545 |
1.841e-06 |
4.749e-05 |
180 |
REGULATION OF GROWTH |
24 |
633 |
1.844e-06 |
4.749e-05 |
181 |
LYMPHOCYTE ACTIVATION |
17 |
342 |
1.847e-06 |
4.749e-05 |
182 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
19 |
422 |
1.976e-06 |
5.052e-05 |
183 |
REGULATION OF KINASE ACTIVITY |
27 |
776 |
2.087e-06 |
5.307e-05 |
184 |
FEMALE SEX DIFFERENTIATION |
10 |
116 |
2.213e-06 |
5.567e-05 |
185 |
POSITIVE REGULATION OF GROWTH |
14 |
238 |
2.207e-06 |
5.567e-05 |
186 |
HOMEOSTATIC PROCESS |
38 |
1337 |
2.28e-06 |
5.704e-05 |
187 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
30 |
926 |
2.342e-06 |
5.827e-05 |
188 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
22 |
554 |
2.403e-06 |
5.854e-05 |
189 |
REGULATION OF NEURON DIFFERENTIATION |
22 |
554 |
2.403e-06 |
5.854e-05 |
190 |
MAMMARY GLAND DEVELOPMENT |
10 |
117 |
2.394e-06 |
5.854e-05 |
191 |
HEMOSTASIS |
16 |
311 |
2.4e-06 |
5.854e-05 |
192 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
25 |
689 |
2.441e-06 |
5.916e-05 |
193 |
RESPONSE TO TOXIC SUBSTANCE |
14 |
241 |
2.556e-06 |
6.162e-05 |
194 |
CELL MOTILITY |
28 |
835 |
2.718e-06 |
6.441e-05 |
195 |
REGULATION OF HEMOPOIESIS |
16 |
314 |
2.716e-06 |
6.441e-05 |
196 |
LOCALIZATION OF CELL |
28 |
835 |
2.718e-06 |
6.441e-05 |
197 |
RESPONSE TO OXIDATIVE STRESS |
17 |
352 |
2.727e-06 |
6.441e-05 |
198 |
LYMPHOCYTE DIFFERENTIATION |
13 |
209 |
2.768e-06 |
6.504e-05 |
199 |
GLUCOSE METABOLIC PROCESS |
10 |
119 |
2.793e-06 |
6.53e-05 |
200 |
RESPONSE TO BIOTIC STIMULUS |
29 |
886 |
2.864e-06 |
6.663e-05 |
201 |
EMBRYONIC ORGAN MORPHOGENESIS |
15 |
279 |
2.913e-06 |
6.743e-05 |
202 |
DIGESTIVE SYSTEM DEVELOPMENT |
11 |
148 |
2.969e-06 |
6.839e-05 |
203 |
FACE DEVELOPMENT |
7 |
50 |
2.997e-06 |
6.869e-05 |
204 |
PURINE CONTAINING COMPOUND METABOLIC PROCESS |
18 |
394 |
3.021e-06 |
6.889e-05 |
205 |
POSITIVE REGULATION OF PROTEIN SECRETION |
13 |
211 |
3.074e-06 |
6.978e-05 |
206 |
REGULATION OF HORMONE LEVELS |
20 |
478 |
3.222e-06 |
7.278e-05 |
207 |
MUSCLE SYSTEM PROCESS |
15 |
282 |
3.32e-06 |
7.464e-05 |
208 |
MULTI MULTICELLULAR ORGANISM PROCESS |
13 |
213 |
3.411e-06 |
7.631e-05 |
209 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
32 |
1047 |
3.585e-06 |
7.981e-05 |
210 |
LUNG EPITHELIUM DEVELOPMENT |
6 |
34 |
3.859e-06 |
8.551e-05 |
211 |
SMALL MOLECULE BIOSYNTHETIC PROCESS |
19 |
443 |
4.005e-06 |
8.8e-05 |
212 |
RESPONSE TO BACTERIUM |
21 |
528 |
4.009e-06 |
8.8e-05 |
213 |
RESPONSE TO PEPTIDE |
18 |
404 |
4.281e-06 |
9.351e-05 |
214 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
17 |
365 |
4.428e-06 |
9.627e-05 |
215 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
7 |
53 |
4.478e-06 |
9.691e-05 |
216 |
NADH METABOLIC PROCESS |
6 |
35 |
4.609e-06 |
9.928e-05 |
217 |
OSTEOBLAST DIFFERENTIATION |
10 |
126 |
4.681e-06 |
0.0001004 |
218 |
NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS |
21 |
535 |
4.913e-06 |
0.0001044 |
219 |
CATABOLIC PROCESS |
45 |
1773 |
4.901e-06 |
0.0001044 |
220 |
POSITIVE REGULATION OF BINDING |
10 |
127 |
5.025e-06 |
0.0001063 |
221 |
EXTRACELLULAR MATRIX DISASSEMBLY |
8 |
76 |
5.27e-06 |
0.000111 |
222 |
REGULATION OF CELL ADHESION |
23 |
629 |
5.546e-06 |
0.0001162 |
223 |
CELLULAR HOMEOSTASIS |
24 |
676 |
5.667e-06 |
0.0001182 |
224 |
MESENCHYME DEVELOPMENT |
12 |
190 |
5.742e-06 |
0.0001193 |
225 |
NAD METABOLIC PROCESS |
7 |
55 |
5.769e-06 |
0.0001193 |
226 |
COFACTOR METABOLIC PROCESS |
16 |
334 |
5.969e-06 |
0.0001229 |
227 |
NEGATIVE REGULATION OF CELL DEATH |
28 |
872 |
6.164e-06 |
0.0001263 |
228 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
9 |
103 |
6.417e-06 |
0.0001298 |
229 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
9 |
103 |
6.417e-06 |
0.0001298 |
230 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
9 |
103 |
6.417e-06 |
0.0001298 |
231 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
56 |
6.523e-06 |
0.0001314 |
232 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
10 |
131 |
6.632e-06 |
0.000133 |
233 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
14 |
262 |
6.716e-06 |
0.0001336 |
234 |
UROGENITAL SYSTEM DEVELOPMENT |
15 |
299 |
6.75e-06 |
0.0001336 |
235 |
DEVELOPMENTAL MATURATION |
12 |
193 |
6.74e-06 |
0.0001336 |
236 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
8 |
79 |
7.058e-06 |
0.0001392 |
237 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
20 |
505 |
7.295e-06 |
0.0001432 |
238 |
POSITIVE REGULATION OF HEMOPOIESIS |
11 |
163 |
7.535e-06 |
0.0001473 |
239 |
COENZYME METABOLIC PROCESS |
14 |
265 |
7.648e-06 |
0.0001489 |
240 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
31 |
1036 |
7.884e-06 |
0.0001522 |
241 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
31 |
1036 |
7.884e-06 |
0.0001522 |
242 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
24 |
691 |
8.181e-06 |
0.0001573 |
243 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
40 |
1527 |
8.615e-06 |
0.000165 |
244 |
REGULATION OF SUPEROXIDE METABOLIC PROCESS |
5 |
23 |
8.696e-06 |
0.0001658 |
245 |
OXIDOREDUCTION COENZYME METABOLIC PROCESS |
9 |
107 |
8.774e-06 |
0.0001666 |
246 |
ATP GENERATION FROM ADP |
6 |
39 |
8.879e-06 |
0.000168 |
247 |
CHONDROCYTE DIFFERENTIATION |
7 |
60 |
1.041e-05 |
0.000196 |
248 |
IN UTERO EMBRYONIC DEVELOPMENT |
15 |
311 |
1.08e-05 |
0.000202 |
249 |
LIPID METABOLIC PROCESS |
33 |
1158 |
1.081e-05 |
0.000202 |
250 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
42 |
1656 |
1.092e-05 |
0.0002032 |
251 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
84 |
1.117e-05 |
0.0002071 |
252 |
REGULATION OF SUPEROXIDE ANION GENERATION |
4 |
12 |
1.143e-05 |
0.000211 |
253 |
EMBRYONIC DIGIT MORPHOGENESIS |
7 |
61 |
1.163e-05 |
0.0002139 |
254 |
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS |
13 |
239 |
1.189e-05 |
0.0002178 |
255 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
8 |
85 |
1.22e-05 |
0.0002226 |
256 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
22 |
616 |
1.289e-05 |
0.0002343 |
257 |
REGULATION OF TISSUE REMODELING |
7 |
62 |
1.297e-05 |
0.0002348 |
258 |
FOREBRAIN DEVELOPMENT |
16 |
357 |
1.371e-05 |
0.0002472 |
259 |
REGULATION OF CARTILAGE DEVELOPMENT |
7 |
63 |
1.443e-05 |
0.0002573 |
260 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
10 |
143 |
1.439e-05 |
0.0002573 |
261 |
PHOSPHORYLATION |
34 |
1228 |
1.435e-05 |
0.0002573 |
262 |
GLIOGENESIS |
11 |
175 |
1.476e-05 |
0.0002622 |
263 |
CELLULAR RESPONSE TO STRESS |
40 |
1565 |
1.529e-05 |
0.0002706 |
264 |
NEURON PROJECTION MORPHOGENESIS |
17 |
402 |
1.563e-05 |
0.0002755 |
265 |
OVULATION CYCLE PROCESS |
8 |
88 |
1.577e-05 |
0.0002769 |
266 |
REGULATION OF PROTEIN ACETYLATION |
7 |
64 |
1.603e-05 |
0.0002794 |
267 |
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS |
7 |
64 |
1.603e-05 |
0.0002794 |
268 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
4 |
13 |
1.634e-05 |
0.0002817 |
269 |
NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
4 |
13 |
1.634e-05 |
0.0002817 |
270 |
REGULATION OF HISTONE PHOSPHORYLATION |
4 |
13 |
1.634e-05 |
0.0002817 |
271 |
BLOOD VESSEL MORPHOGENESIS |
16 |
364 |
1.74e-05 |
0.0002988 |
272 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
24 |
724 |
1.762e-05 |
0.000301 |
273 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
39 |
1518 |
1.766e-05 |
0.000301 |
274 |
PYRUVATE METABOLIC PROCESS |
7 |
65 |
1.778e-05 |
0.0003019 |
275 |
ACTIN FILAMENT BASED PROCESS |
18 |
450 |
1.851e-05 |
0.0003131 |
276 |
CELL PART MORPHOGENESIS |
22 |
633 |
1.958e-05 |
0.0003301 |
277 |
GLYCOSYL COMPOUND METABOLIC PROCESS |
16 |
368 |
1.989e-05 |
0.0003342 |
278 |
EXOCRINE SYSTEM DEVELOPMENT |
6 |
45 |
2.08e-05 |
0.0003463 |
279 |
NEGATIVE REGULATION OF CHROMATIN MODIFICATION |
6 |
45 |
2.08e-05 |
0.0003463 |
280 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
19 |
498 |
2.084e-05 |
0.0003463 |
281 |
NEURON DEVELOPMENT |
23 |
687 |
2.275e-05 |
0.000374 |
282 |
LEUKOCYTE ACTIVATION |
17 |
414 |
2.275e-05 |
0.000374 |
283 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
4 |
14 |
2.266e-05 |
0.000374 |
284 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
8 |
93 |
2.366e-05 |
0.0003864 |
285 |
ANGIOGENESIS |
14 |
293 |
2.361e-05 |
0.0003864 |
286 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
10 |
152 |
2.446e-05 |
0.0003979 |
287 |
REGULATION OF SYSTEM PROCESS |
19 |
507 |
2.663e-05 |
0.0004318 |
288 |
ADP METABOLIC PROCESS |
6 |
47 |
2.685e-05 |
0.0004338 |
289 |
ENDOCRINE SYSTEM DEVELOPMENT |
9 |
123 |
2.703e-05 |
0.0004351 |
290 |
SYSTEM PROCESS |
43 |
1785 |
2.935e-05 |
0.000471 |
291 |
MYELOID LEUKOCYTE DIFFERENTIATION |
8 |
96 |
2.982e-05 |
0.0004769 |
292 |
MYELOID CELL DIFFERENTIATION |
11 |
189 |
3.02e-05 |
0.0004812 |
293 |
CELL PROJECTION ORGANIZATION |
27 |
902 |
3.146e-05 |
0.0004997 |
294 |
VASCULATURE DEVELOPMENT |
18 |
469 |
3.192e-05 |
0.0005051 |
295 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
19 |
514 |
3.209e-05 |
0.0005062 |
296 |
HEXOSE METABOLIC PROCESS |
10 |
157 |
3.231e-05 |
0.0005078 |
297 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
11 |
191 |
3.327e-05 |
0.0005212 |
298 |
HEXOSE CATABOLIC PROCESS |
6 |
49 |
3.424e-05 |
0.0005314 |
299 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
6 |
49 |
3.424e-05 |
0.0005314 |
300 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
5 |
30 |
3.426e-05 |
0.0005314 |
301 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
46 |
1977 |
3.505e-05 |
0.0005418 |
302 |
SINGLE ORGANISM BIOSYNTHETIC PROCESS |
35 |
1340 |
3.585e-05 |
0.0005523 |
303 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
99 |
3.727e-05 |
0.0005724 |
304 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
6 |
50 |
3.85e-05 |
0.0005835 |
305 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
22 |
662 |
3.848e-05 |
0.0005835 |
306 |
RESPONSE TO GAMMA RADIATION |
6 |
50 |
3.85e-05 |
0.0005835 |
307 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
22 |
662 |
3.848e-05 |
0.0005835 |
308 |
FEMALE GENITALIA DEVELOPMENT |
4 |
16 |
4.038e-05 |
0.00061 |
309 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
24 |
767 |
4.435e-05 |
0.0006678 |
310 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
17 |
437 |
4.485e-05 |
0.0006732 |
311 |
POSITIVE REGULATION OF KINASE ACTIVITY |
18 |
482 |
4.553e-05 |
0.0006768 |
312 |
CELLULAR GLUCOSE HOMEOSTASIS |
7 |
75 |
4.552e-05 |
0.0006768 |
313 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
7 |
75 |
4.552e-05 |
0.0006768 |
314 |
ENDOCARDIAL CUSHION DEVELOPMENT |
5 |
32 |
4.742e-05 |
0.0006983 |
315 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
9 |
132 |
4.722e-05 |
0.0006983 |
316 |
BLOOD VESSEL REMODELING |
5 |
32 |
4.742e-05 |
0.0006983 |
317 |
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
4 |
17 |
5.228e-05 |
0.0007649 |
318 |
REGULATION OF HISTONE H3 K9 METHYLATION |
4 |
17 |
5.228e-05 |
0.0007649 |
319 |
RESPONSE TO VITAMIN D |
5 |
33 |
5.532e-05 |
0.000806 |
320 |
MONOSACCHARIDE METABOLIC PROCESS |
11 |
202 |
5.543e-05 |
0.000806 |
321 |
REGULATION OF CHROMOSOME ORGANIZATION |
13 |
278 |
5.757e-05 |
0.0008346 |
322 |
RESPONSE TO ETHANOL |
9 |
136 |
5.963e-05 |
0.0008617 |
323 |
CELLULAR RESPONSE TO RADIATION |
9 |
137 |
6.313e-05 |
0.0009094 |
324 |
HEART VALVE DEVELOPMENT |
5 |
34 |
6.419e-05 |
0.0009219 |
325 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
16 |
406 |
6.46e-05 |
0.0009248 |
326 |
RESPONSE TO RETINOIC ACID |
8 |
107 |
6.507e-05 |
0.0009287 |
327 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
6 |
55 |
6.663e-05 |
0.0009452 |
328 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
6 |
55 |
6.663e-05 |
0.0009452 |
329 |
CELL DEATH |
28 |
1001 |
7.301e-05 |
0.001033 |
330 |
RESPONSE TO MINERALOCORTICOID |
5 |
35 |
7.412e-05 |
0.001045 |
331 |
REGULATION OF FIBROBLAST PROLIFERATION |
7 |
81 |
7.479e-05 |
0.001051 |
332 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
15 |
368 |
7.515e-05 |
0.001053 |
333 |
REGULATION OF RESPONSE TO WOUNDING |
16 |
413 |
7.892e-05 |
0.001099 |
334 |
RESPONSE TO RADIATION |
16 |
413 |
7.892e-05 |
0.001099 |
335 |
IMMUNE SYSTEM PROCESS |
45 |
1984 |
7.947e-05 |
0.001104 |
336 |
NEGATIVE REGULATION OF TRANSPORT |
17 |
458 |
7.986e-05 |
0.001106 |
337 |
SINGLE ORGANISM CELL ADHESION |
17 |
459 |
8.2e-05 |
0.001132 |
338 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
8 |
111 |
8.44e-05 |
0.001162 |
339 |
NEGATIVE REGULATION OF HISTONE MODIFICATION |
5 |
36 |
8.519e-05 |
0.001169 |
340 |
COGNITION |
12 |
251 |
8.989e-05 |
0.00123 |
341 |
POSITIVE REGULATION OF CELL CYCLE |
14 |
332 |
9.119e-05 |
0.001244 |
342 |
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS |
7 |
84 |
9.434e-05 |
0.00128 |
343 |
POSITIVE REGULATION OF OSSIFICATION |
7 |
84 |
9.434e-05 |
0.00128 |
344 |
REGULATION OF CELL PROJECTION ORGANIZATION |
19 |
558 |
9.574e-05 |
0.001291 |
345 |
REGULATION OF STEM CELL DIFFERENTIATION |
8 |
113 |
9.573e-05 |
0.001291 |
346 |
GLIAL CELL MIGRATION |
5 |
37 |
9.75e-05 |
0.001311 |
347 |
RESPONSE TO IONIZING RADIATION |
9 |
145 |
9.787e-05 |
0.001312 |
348 |
MONOSACCHARIDE CATABOLIC PROCESS |
6 |
59 |
9.928e-05 |
0.001327 |
349 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
4 |
20 |
0.0001033 |
0.001373 |
350 |
TONGUE DEVELOPMENT |
4 |
20 |
0.0001033 |
0.001373 |
351 |
LEUKOCYTE CELL CELL ADHESION |
12 |
255 |
0.0001044 |
0.001384 |
352 |
CELLULAR COMPONENT DISASSEMBLY |
18 |
515 |
0.0001057 |
0.001397 |
353 |
REGULATION OF MAPK CASCADE |
21 |
660 |
0.0001069 |
0.001409 |
354 |
REGULATION OF MUSCLE CONTRACTION |
9 |
147 |
0.0001087 |
0.001421 |
355 |
RESPONSE TO INTERLEUKIN 1 |
8 |
115 |
0.0001083 |
0.001421 |
356 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
29 |
1079 |
0.0001084 |
0.001421 |
357 |
REGULATION OF DOUBLE STRAND BREAK REPAIR |
5 |
38 |
0.0001111 |
0.00144 |
358 |
COLLAGEN FIBRIL ORGANIZATION |
5 |
38 |
0.0001111 |
0.00144 |
359 |
MESENCHYME MORPHOGENESIS |
5 |
38 |
0.0001111 |
0.00144 |
360 |
REGULATION OF DNA METABOLIC PROCESS |
14 |
340 |
0.0001172 |
0.001515 |
361 |
NUCLEOTIDE PHOSPHORYLATION |
6 |
61 |
0.0001198 |
0.00154 |
362 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
6 |
61 |
0.0001198 |
0.00154 |
363 |
SINGLE ORGANISM BEHAVIOR |
15 |
384 |
0.0001204 |
0.001544 |
364 |
RESPONSE TO GROWTH FACTOR |
17 |
475 |
0.000124 |
0.001585 |
365 |
ANATOMICAL STRUCTURE MATURATION |
5 |
39 |
0.0001262 |
0.001608 |
366 |
REGULATION OF STEM CELL PROLIFERATION |
7 |
88 |
0.0001267 |
0.001608 |
367 |
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION |
9 |
150 |
0.0001268 |
0.001608 |
368 |
PEPTIDYL TYROSINE MODIFICATION |
10 |
186 |
0.000134 |
0.001689 |
369 |
NEGATIVE REGULATION OF CELL ADHESION |
11 |
223 |
0.000134 |
0.001689 |
370 |
REGULATION OF HORMONE SECRETION |
12 |
262 |
0.0001346 |
0.001693 |
371 |
B CELL DIFFERENTIATION |
7 |
89 |
0.000136 |
0.001706 |
372 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
13 |
303 |
0.0001367 |
0.00171 |
373 |
MESONEPHROS DEVELOPMENT |
7 |
90 |
0.0001459 |
0.001821 |
374 |
REGULATION OF CELL GROWTH |
15 |
391 |
0.0001468 |
0.001826 |
375 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
4 |
22 |
0.0001529 |
0.001882 |
376 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
4 |
22 |
0.0001529 |
0.001882 |
377 |
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
4 |
22 |
0.0001529 |
0.001882 |
378 |
ERK1 AND ERK2 CASCADE |
4 |
22 |
0.0001529 |
0.001882 |
379 |
SEX DIFFERENTIATION |
12 |
266 |
0.0001551 |
0.001904 |
380 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
10 |
191 |
0.0001664 |
0.002038 |
381 |
CELLULAR RESPONSE TO RETINOIC ACID |
6 |
65 |
0.0001709 |
0.002076 |
382 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
9 |
156 |
0.0001707 |
0.002076 |
383 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
9 |
156 |
0.0001707 |
0.002076 |
384 |
CARBOXYLIC ACID BIOSYNTHETIC PROCESS |
12 |
270 |
0.0001781 |
0.002153 |
385 |
ORGANIC ACID BIOSYNTHETIC PROCESS |
12 |
270 |
0.0001781 |
0.002153 |
386 |
REGULATION OF DNA BINDING |
7 |
93 |
0.0001792 |
0.00216 |
387 |
POSITIVE REGULATION OF DNA BINDING |
5 |
42 |
0.0001807 |
0.002167 |
388 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
5 |
42 |
0.0001807 |
0.002167 |
389 |
CHROMATIN MODIFICATION |
18 |
539 |
0.0001858 |
0.002222 |
390 |
KIDNEY EPITHELIUM DEVELOPMENT |
8 |
125 |
0.0001932 |
0.002305 |
391 |
RESPONSE TO ELECTRICAL STIMULUS |
5 |
43 |
0.0002024 |
0.002403 |
392 |
MACROMOLECULE DEACYLATION |
6 |
67 |
0.0002021 |
0.002403 |
393 |
SULFUR COMPOUND METABOLIC PROCESS |
14 |
359 |
0.0002059 |
0.002438 |
394 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
10 |
197 |
0.0002139 |
0.002526 |
395 |
ORGAN GROWTH |
6 |
68 |
0.0002194 |
0.002565 |
396 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
7 |
96 |
0.0002184 |
0.002565 |
397 |
CARDIOCYTE DIFFERENTIATION |
7 |
96 |
0.0002184 |
0.002565 |
398 |
REGULATION OF PHAGOCYTOSIS |
6 |
68 |
0.0002194 |
0.002565 |
399 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
5 |
44 |
0.000226 |
0.002629 |
400 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
9 |
162 |
0.0002265 |
0.002629 |
401 |
REGULATION OF MAP KINASE ACTIVITY |
13 |
319 |
0.0002264 |
0.002629 |
402 |
STEROID METABOLIC PROCESS |
11 |
237 |
0.0002276 |
0.002635 |
403 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
14 |
363 |
0.0002307 |
0.002663 |
404 |
INFLAMMATORY RESPONSE |
16 |
454 |
0.0002329 |
0.002682 |
405 |
NEGATIVE REGULATION OF OSSIFICATION |
6 |
69 |
0.0002378 |
0.002718 |
406 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
9 |
163 |
0.0002372 |
0.002718 |
407 |
RESPONSE TO ACTIVITY |
6 |
69 |
0.0002378 |
0.002718 |
408 |
NEGATIVE REGULATION OF SECRETION |
10 |
200 |
0.0002416 |
0.002755 |
409 |
PROTEIN COMPLEX BIOGENESIS |
29 |
1132 |
0.0002443 |
0.002773 |
410 |
PROTEIN COMPLEX ASSEMBLY |
29 |
1132 |
0.0002443 |
0.002773 |
411 |
REGULATION OF CELL MORPHOGENESIS |
18 |
552 |
0.0002483 |
0.002811 |
412 |
CELLULAR LIPID METABOLIC PROCESS |
25 |
913 |
0.0002498 |
0.002821 |
413 |
CIRCULATORY SYSTEM PROCESS |
14 |
366 |
0.0002508 |
0.002826 |
414 |
ENDOCHONDRAL BONE MORPHOGENESIS |
5 |
45 |
0.0002517 |
0.002829 |
415 |
LUNG CELL DIFFERENTIATION |
4 |
25 |
0.0002566 |
0.002875 |
416 |
ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS |
27 |
1024 |
0.0002571 |
0.002875 |
417 |
LEARNING |
8 |
131 |
0.0002663 |
0.002965 |
418 |
NEGATIVE REGULATION OF BINDING |
8 |
131 |
0.0002663 |
0.002965 |
419 |
REGULATION OF EPITHELIAL CELL MIGRATION |
9 |
166 |
0.0002716 |
0.003016 |
420 |
REGULATION OF ORGAN MORPHOGENESIS |
11 |
242 |
0.0002724 |
0.003017 |
421 |
RESPONSE TO COCAINE |
5 |
46 |
0.0002795 |
0.003078 |
422 |
B CELL ACTIVATION |
8 |
132 |
0.0002805 |
0.003078 |
423 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
46 |
0.0002795 |
0.003078 |
424 |
MAINTENANCE OF CELL NUMBER |
8 |
132 |
0.0002805 |
0.003078 |
425 |
BIOLOGICAL ADHESION |
27 |
1032 |
0.0002907 |
0.003182 |
426 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
12 |
285 |
0.0002925 |
0.003194 |
427 |
RESPONSE TO INSULIN |
10 |
205 |
0.0002944 |
0.0032 |
428 |
NEURON PROJECTION GUIDANCE |
10 |
205 |
0.0002944 |
0.0032 |
429 |
RESPONSE TO CARBOHYDRATE |
9 |
168 |
0.0002968 |
0.003204 |
430 |
SMALL MOLECULE CATABOLIC PROCESS |
13 |
328 |
0.0002961 |
0.003204 |
431 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
14 |
372 |
0.0002958 |
0.003204 |
432 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
4 |
26 |
0.0003003 |
0.003212 |
433 |
POSITIVE REGULATION OF TISSUE REMODELING |
4 |
26 |
0.0003003 |
0.003212 |
434 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
4 |
26 |
0.0003003 |
0.003212 |
435 |
REGULATION OF CELL FATE COMMITMENT |
4 |
26 |
0.0003003 |
0.003212 |
436 |
POSITIVE REGULATION OF CELL FATE COMMITMENT |
3 |
11 |
0.0003062 |
0.003253 |
437 |
CREATINE METABOLIC PROCESS |
3 |
11 |
0.0003062 |
0.003253 |
438 |
POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS |
3 |
11 |
0.0003062 |
0.003253 |
439 |
REGULATION OF CYTOKINE PRODUCTION |
18 |
563 |
0.0003147 |
0.003336 |
440 |
CELLULAR RESPONSE TO KETONE |
6 |
73 |
0.0003237 |
0.003423 |
441 |
CELL GROWTH |
8 |
135 |
0.0003266 |
0.003446 |
442 |
BEHAVIOR |
17 |
516 |
0.0003274 |
0.003446 |
443 |
REGULATION OF DEVELOPMENTAL GROWTH |
12 |
289 |
0.0003318 |
0.003485 |
444 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
5 |
48 |
0.000342 |
0.00356 |
445 |
RESPONSE TO AMINE |
5 |
48 |
0.000342 |
0.00356 |
446 |
RESPONSE TO AXON INJURY |
5 |
48 |
0.000342 |
0.00356 |
447 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
16 |
470 |
0.000342 |
0.00356 |
448 |
REGULATION OF PEPTIDE SECRETION |
10 |
209 |
0.0003433 |
0.003565 |
449 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
6 |
74 |
0.0003486 |
0.003605 |
450 |
ACTIN MEDIATED CELL CONTRACTION |
6 |
74 |
0.0003486 |
0.003605 |
451 |
REGULATION OF CELL SIZE |
9 |
172 |
0.000353 |
0.003642 |
452 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
7 |
104 |
0.0003573 |
0.003678 |
453 |
ARTERY DEVELOPMENT |
6 |
75 |
0.000375 |
0.003843 |
454 |
NEURAL CREST CELL DIFFERENTIATION |
6 |
75 |
0.000375 |
0.003843 |
455 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
8 |
138 |
0.0003788 |
0.003865 |
456 |
CEREBRAL CORTEX DEVELOPMENT |
7 |
105 |
0.0003788 |
0.003865 |
457 |
ORGANOPHOSPHATE METABOLIC PROCESS |
24 |
885 |
0.0003829 |
0.003898 |
458 |
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
4 |
28 |
0.0004032 |
0.004096 |
459 |
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS |
3 |
12 |
0.0004044 |
0.0041 |
460 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
5 |
50 |
0.0004146 |
0.004176 |
461 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
5 |
50 |
0.0004146 |
0.004176 |
462 |
RESPONSE TO PROGESTERONE |
5 |
50 |
0.0004146 |
0.004176 |
463 |
REGULATION OF T CELL DIFFERENTIATION |
7 |
107 |
0.0004248 |
0.004269 |
464 |
REGULATION OF PEPTIDE TRANSPORT |
11 |
256 |
0.0004389 |
0.004401 |
465 |
REGULATION OF CELL CYCLE |
25 |
949 |
0.0004436 |
0.004439 |
466 |
CELLULAR RESPONSE TO FATTY ACID |
5 |
51 |
0.000455 |
0.004543 |
467 |
PLATELET ACTIVATION |
8 |
142 |
0.0004586 |
0.00456 |
468 |
EPIDERMAL CELL DIFFERENTIATION |
8 |
142 |
0.0004586 |
0.00456 |
469 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
4 |
29 |
0.0004631 |
0.004574 |
470 |
STEM CELL DIVISION |
4 |
29 |
0.0004631 |
0.004574 |
471 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
4 |
29 |
0.0004631 |
0.004574 |
472 |
REGULATION OF CELL ACTIVATION |
16 |
484 |
0.0004712 |
0.004646 |
473 |
UNSATURATED FATTY ACID METABOLIC PROCESS |
7 |
109 |
0.0004751 |
0.004674 |
474 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
10 |
218 |
0.0004785 |
0.004697 |
475 |
LEUKOCYTE MIGRATION |
11 |
259 |
0.0004839 |
0.00474 |
476 |
NEGATIVE REGULATION OF PROTEIN BINDING |
6 |
79 |
0.0004963 |
0.004852 |
477 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
5 |
52 |
0.0004982 |
0.00486 |
478 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
8 |
144 |
0.0005034 |
0.0049 |
479 |
MALE SEX DETERMINATION |
3 |
13 |
0.0005209 |
0.005039 |
480 |
POSITIVE REGULATION OF BONE RESORPTION |
3 |
13 |
0.0005209 |
0.005039 |
481 |
POSITIVE REGULATION OF BONE REMODELING |
3 |
13 |
0.0005209 |
0.005039 |
482 |
SECRETION |
18 |
588 |
0.0005259 |
0.005077 |
483 |
NEGATIVE REGULATION OF MAPK CASCADE |
8 |
145 |
0.0005271 |
0.005078 |
484 |
RESPONSE TO AMPHETAMINE |
4 |
30 |
0.000529 |
0.005086 |
485 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
80 |
0.000531 |
0.005094 |
486 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
5 |
53 |
0.0005445 |
0.005203 |
487 |
REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS |
5 |
53 |
0.0005445 |
0.005203 |
488 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
8 |
146 |
0.0005517 |
0.00526 |
489 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
12 |
306 |
0.000553 |
0.005262 |
490 |
EAR MORPHOGENESIS |
7 |
112 |
0.0005595 |
0.005302 |
491 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
7 |
112 |
0.0005595 |
0.005302 |
492 |
CARBOHYDRATE CATABOLIC PROCESS |
7 |
113 |
0.0005901 |
0.005581 |
493 |
MONOSACCHARIDE BIOSYNTHETIC PROCESS |
5 |
54 |
0.000594 |
0.005595 |
494 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
5 |
54 |
0.000594 |
0.005595 |
495 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
9 |
185 |
0.0005994 |
0.005634 |
496 |
POSITIVE REGULATION OF CELL GROWTH |
8 |
148 |
0.0006036 |
0.00564 |
497 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
4 |
31 |
0.0006014 |
0.00564 |
498 |
GAMETE GENERATION |
18 |
595 |
0.0006035 |
0.00564 |
499 |
EPITHELIAL CELL DEVELOPMENT |
9 |
186 |
0.000623 |
0.005798 |
500 |
NOTCH SIGNALING PATHWAY |
7 |
114 |
0.0006221 |
0.005798 |
501 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
3 |
14 |
0.0006568 |
0.006087 |
502 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
3 |
14 |
0.0006568 |
0.006087 |
503 |
CHROMATIN REMODELING |
8 |
150 |
0.0006594 |
0.0061 |
504 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
14 |
404 |
0.0006708 |
0.006193 |
505 |
SALIVARY GLAND DEVELOPMENT |
4 |
32 |
0.0006805 |
0.006246 |
506 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
4 |
32 |
0.0006805 |
0.006246 |
507 |
TELENCEPHALON DEVELOPMENT |
10 |
228 |
0.0006779 |
0.006246 |
508 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
5 |
56 |
0.0007029 |
0.006383 |
509 |
REGULATION OF HISTONE METHYLATION |
5 |
56 |
0.0007029 |
0.006383 |
510 |
ALPHA AMINO ACID METABOLIC PROCESS |
10 |
229 |
0.0007011 |
0.006383 |
511 |
PROTEIN TARGETING |
14 |
406 |
0.0007038 |
0.006383 |
512 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
5 |
56 |
0.0007029 |
0.006383 |
513 |
OUTFLOW TRACT MORPHOGENESIS |
5 |
56 |
0.0007029 |
0.006383 |
514 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
7 |
117 |
0.0007262 |
0.006561 |
515 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
190 |
0.0007255 |
0.006561 |
516 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
6 |
85 |
0.0007333 |
0.006613 |
517 |
PALLIUM DEVELOPMENT |
8 |
153 |
0.0007509 |
0.006758 |
518 |
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
4 |
33 |
0.0007668 |
0.006822 |
519 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
4 |
33 |
0.0007668 |
0.006822 |
520 |
REGULATION OF BONE RESORPTION |
4 |
33 |
0.0007668 |
0.006822 |
521 |
EMBRYONIC EYE MORPHOGENESIS |
4 |
33 |
0.0007668 |
0.006822 |
522 |
APOPTOTIC MITOCHONDRIAL CHANGES |
5 |
57 |
0.0007626 |
0.006822 |
523 |
REGULATION OF CELL AGING |
4 |
33 |
0.0007668 |
0.006822 |
524 |
CELL CELL ADHESION |
18 |
608 |
0.0007741 |
0.006867 |
525 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
10 |
232 |
0.0007748 |
0.006867 |
526 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
23 |
876 |
0.0007873 |
0.006965 |
527 |
MUSCLE CONTRACTION |
10 |
233 |
0.0008008 |
0.00707 |
528 |
POLYAMINE METABOLIC PROCESS |
3 |
15 |
0.0008133 |
0.007154 |
529 |
T CELL APOPTOTIC PROCESS |
3 |
15 |
0.0008133 |
0.007154 |
530 |
CHROMATIN ORGANIZATION |
19 |
663 |
0.0008188 |
0.007189 |
531 |
MACROMOLECULAR COMPLEX ASSEMBLY |
32 |
1398 |
0.0008232 |
0.007214 |
532 |
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS |
5 |
58 |
0.000826 |
0.007225 |
533 |
PROTEIN LOCALIZATION TO NUCLEUS |
8 |
156 |
0.0008523 |
0.00744 |
534 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
34 |
0.0008605 |
0.007484 |
535 |
PROTEIN KINASE B SIGNALING |
4 |
34 |
0.0008605 |
0.007484 |
536 |
REGULATION OF MUSCLE SYSTEM PROCESS |
9 |
195 |
0.0008724 |
0.007574 |
537 |
TAXIS |
15 |
464 |
0.0008841 |
0.007661 |
538 |
CARBOHYDRATE BIOSYNTHETIC PROCESS |
7 |
121 |
0.000886 |
0.007663 |
539 |
NEGATIVE REGULATION OF CELL ACTIVATION |
8 |
158 |
0.0009258 |
0.007977 |
540 |
RESPONSE TO PURINE CONTAINING COMPOUND |
8 |
158 |
0.0009258 |
0.007977 |
541 |
EPITHELIAL CELL PROLIFERATION |
6 |
89 |
0.0009344 |
0.008036 |
542 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
9 |
197 |
0.0009376 |
0.008049 |
543 |
PROTEIN PHOSPHORYLATION |
24 |
944 |
0.0009461 |
0.008107 |
544 |
REGULATION OF PROTEIN OLIGOMERIZATION |
4 |
35 |
0.0009619 |
0.00819 |
545 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
5 |
60 |
0.0009646 |
0.00819 |
546 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
5 |
60 |
0.0009646 |
0.00819 |
547 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
60 |
0.0009646 |
0.00819 |
548 |
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT |
4 |
35 |
0.0009619 |
0.00819 |
549 |
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY |
3 |
16 |
0.0009917 |
0.008314 |
550 |
NOTCH RECEPTOR PROCESSING |
3 |
16 |
0.0009917 |
0.008314 |
551 |
NEGATIVE REGULATION OF HISTONE METHYLATION |
3 |
16 |
0.0009917 |
0.008314 |
552 |
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT |
3 |
16 |
0.0009917 |
0.008314 |
553 |
REGULATION OF CELL MATRIX ADHESION |
6 |
90 |
0.0009907 |
0.008314 |
554 |
REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS |
3 |
16 |
0.0009917 |
0.008314 |
555 |
REGULATION OF INTRACELLULAR TRANSPORT |
18 |
621 |
0.0009845 |
0.008314 |
556 |
CELLULAR CHEMICAL HOMEOSTASIS |
17 |
570 |
0.0009961 |
0.008336 |
557 |
REGULATION OF ENDOCYTOSIS |
9 |
199 |
0.001007 |
0.008409 |
558 |
INOSITOL LIPID MEDIATED SIGNALING |
7 |
124 |
0.001023 |
0.008532 |
559 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
13 |
375 |
0.001033 |
0.008601 |
560 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
5 |
61 |
0.00104 |
0.008611 |
561 |
SEXUAL REPRODUCTION |
20 |
730 |
0.001039 |
0.008611 |
562 |
OVARIAN FOLLICLE DEVELOPMENT |
5 |
61 |
0.00104 |
0.008611 |
563 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
6 |
91 |
0.00105 |
0.008659 |
564 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
15 |
472 |
0.001049 |
0.008659 |
565 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
4 |
36 |
0.001072 |
0.008778 |
566 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
4 |
36 |
0.001072 |
0.008778 |
567 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
36 |
0.001072 |
0.008778 |
568 |
HEAD MORPHOGENESIS |
4 |
36 |
0.001072 |
0.008778 |
569 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
23 |
898 |
0.001095 |
0.008957 |
570 |
REGULATION OF WOUND HEALING |
7 |
126 |
0.001123 |
0.009091 |
571 |
CELLULAR AMINO ACID METABOLIC PROCESS |
12 |
332 |
0.001123 |
0.009091 |
572 |
CARDIAC VENTRICLE MORPHOGENESIS |
5 |
62 |
0.00112 |
0.009091 |
573 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
5 |
62 |
0.00112 |
0.009091 |
574 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS |
5 |
62 |
0.00112 |
0.009091 |
575 |
PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS |
5 |
62 |
0.00112 |
0.009091 |
576 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
8 |
163 |
0.001132 |
0.009144 |
577 |
RESPONSE TO METAL ION |
12 |
333 |
0.001152 |
0.009293 |
578 |
REGULATION OF CELL CELL ADHESION |
13 |
380 |
0.001165 |
0.009375 |
579 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
6 |
93 |
0.001175 |
0.009413 |
580 |
ACTIN FILAMENT BASED MOVEMENT |
6 |
93 |
0.001175 |
0.009413 |
581 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
6 |
93 |
0.001175 |
0.009413 |
582 |
NUCLEOSOME DISASSEMBLY |
3 |
17 |
0.001193 |
0.009424 |
583 |
PROTEIN DNA COMPLEX DISASSEMBLY |
3 |
17 |
0.001193 |
0.009424 |
584 |
BRANCH ELONGATION OF AN EPITHELIUM |
3 |
17 |
0.001193 |
0.009424 |
585 |
APOPTOTIC SIGNALING PATHWAY |
11 |
289 |
0.001188 |
0.009424 |
586 |
CHROMATIN DISASSEMBLY |
3 |
17 |
0.001193 |
0.009424 |
587 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
4 |
37 |
0.00119 |
0.009424 |
588 |
ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY |
4 |
37 |
0.00119 |
0.009424 |
589 |
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY |
4 |
37 |
0.00119 |
0.009424 |
590 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
5 |
63 |
0.001204 |
0.009478 |
591 |
RESPONSE TO OSMOTIC STRESS |
5 |
63 |
0.001204 |
0.009478 |
592 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
7 |
128 |
0.001231 |
0.009678 |
593 |
REGULATION OF CYTOPLASMIC TRANSPORT |
15 |
481 |
0.001265 |
0.009928 |
594 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
12 |
337 |
0.001275 |
0.009958 |
595 |
MUSCLE STRUCTURE DEVELOPMENT |
14 |
432 |
0.001274 |
0.009958 |
596 |
AMINOGLYCAN METABOLIC PROCESS |
8 |
166 |
0.001272 |
0.009958 |